NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Nexalin Technology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.36+0.01 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $49.90M
- P/E (TTM)
- –
- Dividend yield
- –
Nexalin Technology statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Market Cap | $52.01M | $230.55M |
| Enterprise Value | $51.00M | $202.97M |
| PS Ratio | 239.49 | 3.10 |
| PB Ratio | 34.23 | 3.04 |
| P/TBV Ratio | 46.44 | 4.43 |
Enterprise value
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| EV / Sales | 234.86 | 2.91 |
Income (trailing twelve months)
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Revenue | $217.16K | $102.39M |
| Gross Profit | $187.10K | $60.36M |
| Operating Income | -$9.13M | -$4.31M |
| Pretax Income | -$8.99M | -$2.37M |
| Net Income | -$8.99M | -$6.57M |
| EBITDA | -$9.13M | -$1.98M |
| EPS (Diluted) | -$0.48 | -$0.08 |
Margins
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Gross Margin | 86.2% | 55.2% |
| Operating Margin | -4202.5% | -6.04% |
| Pretax Margin | -4139.4% | -4.11% |
| Profit Margin | -4139.4% | -10.5% |
| EBITDA Margin | -4202.5% | -2.67% |
Returns
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Return on Equity (ROE) | -240.3% | -18.2% |
| Return on Assets (ROA) | -187.9% | -13.3% |
| Return on Invested Capital (ROIC) | -2104.7% | -3.69% |
| Return on Capital Employed (ROCE) | -600.6% | -9.07% |
Growth
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 24.2% | 8.85% |
| Revenue Growth (3Y CAGR) | -38.9% | 7.08% |
Balance sheet
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.00M | $36.66M |
| Net Cash (Debt) | $1.00M | $3.92M |
| Net Cash Per Share | $0.05 | $0.28 |
| Equity (Book Value) | $1.52M | $55.33M |
| Book Value Per Share | $0.07 | $2.87 |
| Tangible Book Value | $1.12M | $10.79M |
| Working Capital | $377.35K | $56.72M |
Financial position
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Current Ratio | 1.25 | 2.48 |
| Quick Ratio | 0.71 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.13M | -$566.22K |
Efficiency
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Asset Turnover | 0.05 | 0.58 |
| Inventory Turnover | 0.15 | 2.21 |
| Revenue Per Employee | $27.14K | $322.92K |
| Profits Per Employee | -$1.12M | -$51.88K |
| Employee Count | 8 | 185 |
Dividends and yields
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Earnings Yield | -17.3% | -6.88% |
Shares
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Shares Outstanding | 22,036,400 | 44,302,700 |
| Shares Change (YoY) | 52.1% | 3.36% |
| Shares Change (QoQ) | 6.91% | 0.27% |
| Float | 17,117,100 | 37,462,700 |
| Shares Held by Insiders | 22.3% | 10.5% |
Scores
| Measure | Nexalin Technology | Industry median |
|---|---|---|
| Altman Z-Score | -34.08 | 1.95 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from Nexalin Technology's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.